Effects of gestational age and surface modification on materno-fetal transfer of nanoparticles in murine pregnancy

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Yang, Hui ^a   Sun, Cuiji ^a   Fan, Zhenlin ^a,f   Tian, Xin ^a   Yan, Liang ^b   Du, Libo ^c   Liu, Yang ^c   Chen, Chunying ^a   Liang, Xing Jie ^a   Anderson, Gregory J ^d   Keelan, Jeffrey A ^e   Zhao, Yuliang ^a,b   Nie, Guangjun ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF HIGH ENERGY PHYSICS   (China)

^c INSTITUTE OF CHEMISTRY   (China)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; FERRITIN; GOLD; MACROGOL DERIVATIVE; METAL NANOPARTICLE;

ANIMAL; ARTICLE; BREEDING; CHEMISTRY; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; GESTATIONAL AGE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MOUSE; PLACENTA; PREGNANCY; SURFACE PROPERTY; TISSUE DISTRIBUTION;

ANIMALS; CITRIC ACID; FEMALE; FERRITINS; FETUS; GESTATIONAL AGE; GOLD; INJECTIONS, INTRAVENOUS; MATERNAL-FETAL EXCHANGE; METAL NANOPARTICLES; MICE; PLACENTA; POLYETHYLENE GLYCOLS; PREGNANCY; PREGNANCY, ANIMAL; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84869187892     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00847     Document Type: Article

References (44)

1. Bowman, D. M., van Calster, G. & Friedrichs, S. Nanomaterials and regulation of cosmetics. Nature Nanotech. 5, 92 (2010).
2. Petros, R. A. & DeSimone, J. M. Strategies in the design of nanoparticles for therapeutic applications. Nature Rev. Drug Discov. 9, 615-627 (2010).
3. Augustin, M. A. & Sanguansri, P. Nanostructured materials in the food industry. Adv. Food Nutr. Res. 58, 183-213 (2009).
4. Maynard, A. D. et al. Safe handling of nanotechnology. Nature 444, 267-269 (2006). (Pubitemid 44764087)
5. Oberdorster, G., Oberdorster, E. & Oberdorster, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113, 823-839 (2005). (Pubitemid 40984181)
6. Saunders, M. Transplacental transport of nanomaterials. Wiley Interdiscip. Rev. Nanomed. Nanobiotech. 1, 671-684 (2009).
7. Wick, P. et al. Barrier capacity of human placenta for nanosized materials. Environ. Health Perspect. 118, 432-436 (2010).
8. Keelan, J. A.Nanotoxicology: nanoparticles versus the placenta. Nature Nanotech. 6, 263-264 (2011).
9. Myllynen, P., Pasanen, M. & Vahakangas, K. The fate and effects of xenobiotics in human placenta. Expert. Opin. Drug Metab. Toxicol. 3, 331-346 (2007). (Pubitemid 47316028)
10. Syme, M. R., Paxton, J. W. & Keelan, J. A. Drug transfer and metabolism by the human placenta. Clin. Pharmacokinet. 43, 487-514 (2004). (Pubitemid 38858303)
11. Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505-515 (2008).
12. Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotech. 2, 751-760 (2007). (Pubitemid 350223348)
13. Ema, M., Kobayashi, N., Naya, M., Hanai, S. & Nakanishi, J. Reproductive and developmental toxicity studies of manufactured nanomaterials. Reprod. Toxicol. 30, 343-352 (2010).
14. Bar-Ilan, O., Albrecht, R. M., Fako, V. E.&Furgeson, D. Y. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 5, 1897-1910 (2009).
15. Takeda, K. et al. Nanoparticles transferred from pregnant mice to their offspring can damage the genital and cranial nerve systems. J. Health Sci. 55, 95-102 (2009).
16. Tsuchiya, T., Oguri, I., Yamakoshi, Y. N. & Miyata, N. Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo. FEBS Lett. 393, 139-145 (1996). (Pubitemid 26298248)
17. Yamashita, K. et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nature Nanotech. 6, 321-328 (2011).
18. Shimizu, M. et al. Maternal exposure to nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain development in the mouse. Part. Fibre. Toxicol. 6, 20 (2009).
19. Burton, G. J., Jauniaux, E. & Charnock-Jones, D. S. Human early placental development: potential roles of the endometrial glands. Placenta 28 Suppl A, S64-69 (2007). (Pubitemid 46508697)
20. Chae, J. I. et al. Proteomic analysis of the extraembryonic tissue from cloned porcine embryos. Mol. Cell. Proteomics 5, 1559-1566 (2006).
21. Jansson, T. & Powell, T. L. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin. Sci. (Lond) 113, 1-13 (2007). (Pubitemid 47066020)
22. Schneider, H. & Miller, R. K. Receptor-mediated uptake and transport of macromolecules in the human placenta. Int. J. Dev. Biol. 54, 367-375 (2010).
23. Menezes, V., Malek, A. & Keelan, J. A. Nanoparticulate drug delivery in pregnancy: placental passage and fetal exposure. Curr. Pharm. Biotech. 12, 731-742 (2011).
24. Jia, G. et al. Cytotoxicity of carbon nanomaterials: single-wall nanotube, multiwall nanotube, and fullerene. Environ. Sci. Technol. 39, 1378-1383 (2005). (Pubitemid 40333400)
25. Li, Y. Y. et al. Chirality of glutathione surface coating affects the cytotoxicity of quantum dots. Angew. Chem. Int. Ed. 50, 5860-5864 (2011).
26. Krantz, K. E., Panos, T. C. & Evans, J. Physiology of maternalfetal relationship through the extracorporeal circulation of the human placenta. Am. J. Obstet. Gynecol. 83, 1214-1228 (1962).
27. Schneider, H. The role of the placenta in nutrition of the human fetus. Am. J. Obstet. Gynecol. 164, 967-973 (1991).
28. Watson, E. D. & Cross, J. C. Development of structures and transport functions in the mouse placenta. Physiology 20, 180-193 (2005). (Pubitemid 40807056)
29. Georgiades, P., Ferguson-Smith, A. C.&Burton, G. J. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 23, 3-19 (2002). (Pubitemid 41110436)
30. Enders, A. C. & Blankenship, T. N. Comparative placental structure. Adv. Drug Deliver. Rev. 38, 3-15 (1999). (Pubitemid 29216950)
31. Luebke, R. W. et al. The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J. Toxicol. Environ.Health B Crit. Rev. 9, 1-26 (2006). (Pubitemid 43068296)
32. Miller, M. S. Transplacental lung carcinogenesis: molecular mechanisms and pathogenesis. Toxicol. Appl. Pharmacol. 198, 95-110 (2004). (Pubitemid 38952831)
33. Khlebtsov, N. & Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 40, 1647-1671 (2011).
34. Sun, C. et al. Controlling assembly of paired gold clusters within apoferritin nanoreactor for in vivo kidney targeting and biomedical imaging. J. Am. Chem. Soc. 133, 8617-8624 (2011).
35. Sadauskas, E. et al. Kupffer cells are central in the removal of nanoparticles from the organism. Part. Fibre. Toxicol. 4, 10 (2007).
36. Nicklin, S. & Billington, W. D. Macrophage activity in mouse pregnancy. J. Reprod. Immunol. 1, 117-126 (1979). (Pubitemid 9224705)
37. Wang, W., Knovich, M. A., Coffman, L. G., Torti, F. M. & Torti, S. V. Serum ferritin: Past, present and future. Biochim. Biophys. Acta 1800, 760-769 (2010).
38. Maham, A., Tang, Z., Wu, H., Wang, J. & Lin, Y. Protein-based nanomedicine platforms for drug delivery. Small 5, 1706-1721 (2009).
39. Chu, M. et al. Transfer of quantum dots from pregnant mice to pups across the placental barrier. Small 6, 670-678 (2010).
40. Semmler-Behnke, M. et al. Biodistribution of 1.4-and 18-nm gold particles in rats. Small 4, 2108-2111 (2008).
41. Myllynen, P. K. et al. Kinetics of gold nanoparticles in the human placenta. Reprod. Toxicol. 26, 130-137 (2008).
42. Qiu, Y. et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31, 7606-7619 (2010).
43. Frens, G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature 241, 20-22(1973).
44. Cho, W. S. et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 236, 16-24 (2009).